The Role of P-Glycoprotein and Organic Anion-Transporting Polypeptides in Drug Interactions
- 1 January 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 28 (9), 789-801
- https://doi.org/10.2165/00002018-200528090-00004
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Interaction of Cytochrome P450 3A Inhibitors with P-GlycoproteinJournal of Pharmacology and Experimental Therapeutics, 2002
- Grapefruit Juice Reduces the Oral Bioavailability of Fexofenadine But Not DesloratadineClinical Pharmacokinetics, 2002
- Drug interactions between oral contraceptives and antibioticsPublished by Ovid Technologies (Wolters Kluwer Health) ,2001
- Molecular Identification and Characterization of Novel Members of the Human Organic Anion Transporter (OATP) FamilyBiochemical and Biophysical Research Communications, 2000
- Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 InhibitionClinical Pharmacokinetics, 2000
- P-GLYCOPROTEIN SYSTEM AS A DETERMINANT OF DRUG INTERACTIONS: THE CASE OF DIGOXIN–VERAPAMILPharmacological Research, 1999
- Clinical Pharmacokinetics of TroglitazoneClinical Pharmacokinetics, 1999
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.JCI Insight, 1998
- Oral contraceptive failure rates and oral antibioticsJournal of the American Academy of Dermatology, 1997
- ABC Transporters: From Microorganisms to ManAnnual Review of Cell Biology, 1992